Evaluation of anti-epileptic activity of Xanthium strumarium L

Pharmacologyonline

Volumn 2, Issue , 2010, Pages 850-855

  Senthil Kumar, K K ^a,b   Rajkapoor, B ^a  

^a StPeter's College of Pharmacy   (India)

^b St Johns Pharmacy College   (India)

Author keywords

Anti epileptic activity; Maximal electroshock (mes); Pentylenetetrazole (ptz); Xanthium strumarium l.

Indexed keywords

ANTICONVULSIVE AGENT; DIAZEPAM; METHANOL; PENTETRAZOLE; PETROLEUM ETHER; PHENYTOIN; PLANT EXTRACT; UNCLASSIFIED DRUG; XANTHIUM STRUMARIUM EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; BODY WEIGHT; CLONIC SEIZURE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG SCREENING; ELECTRIC SHOCK; FEMALE; MALE; MYOCLONUS SEIZURE; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; PHYTOCHEMISTRY; RAT; TOXICITY TESTING; WISTAR RAT;

EID: 77957274219     PISSN: None     EISSN: 18278620     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Agharkar SP. Medicinal plants of Bombay presidency, PBI, Scientific Publishers, Jodhpur (India), 1991: 230.
2. Harbone JP. Phytochemical methods, a guide to modern technique of plant analysis (Chapmann and Hall, London), 1973: 1-271.
3. OECD 2002. Acute oral toxicity. Acute oral toxic class method guideline 423 adopted in: Eleventh Addendum to the OECD, guidelines for the testing of chemicals organisation for economical co-operation and development.
4. Balakrishnan S, Pandhi P, Bhargava VK. Effects of Nimodipine on the efficacy of commonly used anti-epileptic drugs in rats. Ind J Exp Biol.1998; 36: 51-54.
5. Kulkarni SK and George B. Significance of long term potentiation in cognitive functions and epilepsy. Ind J Pharmacol. 1999; 31:14-22.
6. Heinemann UE, Draghun E, Fickern J, Stabel and Zhang CL. Strategis for the development of drugs for pharmacological resistant epilepsies. Epilepsia. 1994; 35: S10-S21.
7. Raza MF, Shaheen MI, Choudhary A, Suria AU, Rahman S, Sombati and Delorenzo RJ. Anticonvulsant activities of the FS-1 Sub-fraction isolated from roots of Delphinium denudatum. Phytother. Res. 2001; 15: 426-430.
8. Loscher W, Schmidt D. Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical consideration. Epilepsy Res. 1988; 2: 145-181.
9. Oliveira FA, Almeida RN, Sousa MFV, Barbosa-Filho JM, Diniz SA, Medeiros IA. Anticonvulsant properties of N-salicyloyltryptamine in mice. Pharmacol Biochem Behav. 2001; 68: 199-202.
10. Quintans-Júnior LJ, Almeida RN, Falcão ACGM, Agra MF, Sousa MFV, Barbosa-Filho JM. Avaliação da Atividade anticonvulsivante de plantas do Nordeste Brasileiro. Acta Farm Bonaerense. 2002; 21: 179-184.
11. th edn. Ed. Levy RH, Mattson RH, Meldrum BS, Raven Press, New York. 1995: 4-17.
12. Kupferberg HJ. Antiepileptic drug development program: a cooperative effort of government and industry. Epilepsia. 1989; 30 (Suppl 1): S51-S56.
13. Macdonald RL and Kelly KM. Antiepileptic drug mechanisms of action. Epilapsia.1995; 36: S2-S12.
14. White HS. Clinical significance of animal seizure models and mechanism of action studies of potential antiepileptic drugs. Epilepsia. 1997; 38 (Suppl. 1): 9.
15. Ramanjaneyulu R, Ticku MK. İnteractions of pentamethylenetetrazole and tetrazole analogues with the picrotoxinin site of the benzodiazepine- GABA receptorionophore complex. Eur. J. Pharmacol. 1984; 98: 337-345.
16. De Deyn PP, D'Hooge R, Marescau B and Pei YQ. Chemical model of epilepsy with some reference to their applicability in the development of anticonvulsant. Epilepsy Res. 1992; 12: 87-110.
17. Coulter DA, Hugenard JR and Prince DA. Characterization of the ethosuximide reduction of low-threshold calcium current in thalamic neurons. Ann. Neurol. 1989; 25: 582-593.